Present status of statin therapy

Area of Science:

• Cardiology
• Pharmacology
• Preventive Medicine

Background:

• Statins are key cardioprotective drugs targeting elevated low-density lipoprotein cholesterol (LDL-C).
• Dyslipidemia significantly increases cardiovascular risk, necessitating effective interventions.
• Primary prevention decisions for statin therapy involve balancing absolute risk reduction with factors like LDL-C and C-reactive protein levels.

Purpose of the Study:

• To evaluate the effectiveness of statin therapy, alone and in combination with lifestyle changes, for cardiovascular risk reduction.
• To determine the optimal approach for managing dyslipidemia and reducing mortality risk.

Main Methods:

• Review of existing literature on statin efficacy and combination therapies.
• Analysis of cardiovascular outcomes in patients with dyslipidemia undergoing various treatment regimens.
• Consideration of factors influencing statin initiation for primary prevention.

Main Results:

• Combined statin therapy substantially reduces mortality risk in significantly dyslipidemic individuals.
• Intense exercise combined with statin therapy offers significant mortality risk reduction.
• Lifestyle modifications complement statin therapy for enhanced risk reduction.

Conclusions:

• Statin therapy is a crucial intervention for managing dyslipidemia and reducing cardiovascular mortality.
• Combination therapy, particularly with lifestyle changes like intense exercise, represents an ideal strategy for high-risk individuals.
• Personalized risk assessment is essential for initiating statin therapy in primary prevention.